Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-06-13

FDA Approved: BUPROPION HYDROCHLORIDE XL — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved Actavis Pharma's generic extended-release formulation of bupropion hydrochloride XL under an original ANDA, typically indicated for major depressiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)

Snippet

ORIG AP for BUPROPION HYDROCHLORIDE XL (BUPROPION HYDROCHLORIDE)